Published on Roswell Park Cancer Institute (http://www.roswellpark.org)

Clinical Chief of Gynecologic Oncology
Clinical Chair, Division of Surgical Subspecialties
Roswell Park Cancer Institute
Clinical Professor of Gynecology & Obstetrics
School of Medicine and Biomedical Sciences, State University of New York at Buffalo
Profile
Areas of Expertise: 
Cervical cancer
Endometrial cancer
Ovarian cancer
Uterine fibroid tumors
Vaginal cancer
Vulvar cancer
Research
Research Interests: 
Gynecologic oncology group studies involving clinical and scientific research
Ovarian cancer surgery
Ovarian cancer chemotherapy
Background Information
Education and Training: 
MD - Grant Medical College, University of Mumbai, Mumbai, Maharashtra, India
Residency: 
JJ Hospital-Grant Medical College, Mumbai, Maharashtra, India
Mount Sinai Hospital, Cleveland, OH
Board Certification: 
Obstetrics & Gynecology, American Board of Obstetrics & Gynecology
Gynecologic Oncology, American Board of Obstetrics & Gynecology
Fellowships: 
Roswell Park Cancer Institute, Buffalo, NY
Publications
Publications: 
  • Ali L, Bambach BJ, Kozielski R, Wagner H, Lele S, Mhawech-Fauceglia P. Ovarian yolk sac tumor associated with major fibrosarcoma component in a 13-year-old girl. International journal of gynecological pathology 2010; 29(3):252-255
  • Godoy H, Kesterson JP, Lele S. Tumor lysis syndrome associated with carboplatin and paclitaxel in a woman with recurrent endometrial cancer. International journal of gynaecology and obstetrics 2010; 109(3):254
  • Kesterson JP, Odunsi K, Lele S. High cumulative doses of pegylated liposomal doxorubicin are not associated with cardiac toxicity in patients with gynecologic malignancies. Chemotherapy 2010; 56(2):108-111
  • Matsuzaki J, Old LJ, Shrikant P, Lele S, Qian F, Eppolito C, Tsuji T, Miller A, Beck A, Mhawech-Fauceglia P, Gnjatic S, Odunsi K. Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer. Proceedings of the National Academy of Sciences of the United States of America 2010; 107(17):7875-7880
  • , McCloskey SA, Tchabo NE, Malhotra HK, Odunsi K, Rodabaugh K, Singhal P, Lele S, Jaggernauth W. Adjuvant vaginal brachytherapy alone for high risk localized endometrial cancer as defined by the three major randomized trials of adjuvant pelvic radiation. Gynecologic oncology 2010; 116(3):404-407
  • Mhawech-Fauceglia P, Herrmann FR, Rai H, Tchabo N, Lele S, Izevbaye I, Odunsi K, Cheney RT. IMP3 distinguishes uterine serous carcinoma from endometrial endometrioid adenocarcinoma. American journal of clinical pathology 2010; 133(6):899-908
  • Paczos TA, Ackers S, Odunsi K, Lele S, Mhawech-Fauceglia P. Primary vaginal adenocarcinoma arising in vaginal adenosis after CO2 laser vaporization and 5-fluorouracil therapy. International journal of gynecological pathology 2010; 29(2):193-196
  • Shen J, DiCioccio R, Odunsi K, Lele SB, Zhao H. Novel genetic variants in miR-191 gene and familial ovarian cancer. BMC cancer 2010; 10 :47
  • Beck T, McBee W, Singhal P, Rose P, Krivak T, Ehrenberg H, Lele S. Endometrial stromal sarcoma: Analysis of recurrence following adjuvant treatment. Gynecologic oncology 2010; 116(3 Suppl. 1):228
  • Dewdney S, Brinton L, Pearl M, Lele S, DiSilvestro P, Darcy K, Mannel R, O'Malley D, Ali S, Andaya A, Rimmel B, Babb S, Kizer N, Goodfellow P. Uterine serous carcinoma: Increased familial risk for pancreatic cancer and other Lynch-associated malignancies. Gynecologic oncology 2010; 116(3 Suppl. 1):14
  • DuPont NC, Guru KA, Iskander GB, Odunsi K, Lele SB, Rodabaugh KJ. Instituting a robot-assisted surgery programme at a tertiary care cancer centre. International journal of medical robotics and computer assisted surgery 2010; 6(3):330-333
  • Godoy HE, Mhawech-Fauceglia P, Beck Amy, Miller A, Lele S, Odunsi K. Expression of poly(adenosine diphosphate-ribose) polymerase (PARP) and p53 in epithelial ovarian cancer. Proceedings of the American Association for Cancer Research Annual Meeting 2010; 51:192
  • Kesterson J, Kanis M, Lele S. Evaluation of the role of routine surveillance following treatment of early-stage cervical cancer. Gynecologic oncology 2010; 116(3 Suppl. 1):90
  • Godoy H, Eppolito C, Balu-Iyer S, Lele S, Odunsi K. Dendritic cells loaded with WT-1 and lipid A in a cationic liposome promote tumor immunity in a mouse model of ovarian cancer. Reproductive sciences (Thousand Oaks, Calif.) 2010; 17(3 Suppl.):1013
  • Mhawech-Fauceglia P , Herrmann RF , Kesterson J , Izevbaye I , Lele S , Odunsi K. Prognostic factors in stages II/III/IV and stages III/IV endometrioid and serous adenocarcinoma of the endometrium. European journal of surgical oncology 2010; 36(12):1195-1201
  • Mhawech-Fauceglia P , Wang D , Kesterson J , Clark K , Monhollen L , Odunsi K , Lele S , Liu S. Microarray analysis reveals distinct gene expression profiles among different tumor histology, stage and disease outcomes in endometrial adenocarcinoma. PloS one 2010; 5(11):e15415
  • Kanis M, Kesterson JP, Lele S. The use of cod liver oil by patients receiving pegylated liposomal doxorubicin is associated with a lack of severe palmar-plantar erythrodysesthesia. European journal of gynaecological oncology 2009; 30(4):387-388
  • Kesterson JP, Lele S. Vulvar intraepithelial neoplasia 3 in women less than 35 years. Journal of lower genital tract disease 2009; 13(4):196-199
  • Lin B, White JT, Wu J, Lele S, Old LJ, Hood L, Odunsi K. Deep depletion of abundant serum proteins reveals low-abundant proteins as potential biomarkers for human ovarian cancer. Proteomics. Clinical applications 2009; 3(7):853-861
  • Mhawech-Fauceglia P, Chan A, Keitz B, Lele S, Cheney RT, Starostik P. Microsatellite instability in large cell neuroendocrine carcinoma of the female genital tract. Histopathology 2009; 55(5):621-625
  • Mhawech-Fauceglia P, Herrmann FR, Andrews C, South S, Beck A, Lele S, Odunsi K. 14-3-3sigma Expression and Prognostic Value in Patients with Epithelial Ovarian Carcinoma: a High Throughput Tissue Microarray Analysis. European journal of surgical oncology 2009; 35(7):763-767
  • Mhawech-Fauceglia P, Herrmann FR, Wagner H, Godoy H, Odunsi K, Cheney RT, Lele S. Submission of the entire lymph node dissection for histologic examination in gynecologic-oncologic specimens. Clinical and pathologic relevance. Gynecologic oncology 2009; 115(3):354-356
  • Qian F, Old LJ, Shrikant P, Lele S, Moysich K, Cheney R, Liao J, Beck A, Frederick PJ, Ayyoub M, Valmori D, Matsuzaki J, Andrews C, Tario Jr JD, Mhawech-Fauceglia P, Wallace PK, Villella J, Odunsi K. Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancer. Cancer research 2009; 69(13):5498-5504
  • Tayo BO, DiCioccio RA, Liang Y, Trevisan M, Cooper RS, Lele S, Sucheston L, Piver SM, Odunsi K. Complex segregation analysis of pedigrees from the Gilda Radner Familial Ovarian Cancer Registry reveals evidence for mendelian dominant inheritance. PloS one 2009; 4(6):e5939
  • Tchabo NE, McCloskey S, Mashtare TL, Andrews C, Singh AK, Mhawech-Fauceglia P, Odunsi K, Lele S, Jaggernauth W. Treatment of early-stage uterine papillary serous carcinoma at Roswell Park Cancer Institute, 1992-2006. Gynecologic oncology 2009; 115(2):249-256
  • Tchabo NE, Old LJ, Lele S, Andrews C, Liao J, Miliotto AJ, Beck AF, Villella J, Caballero OL, Mhawech-Fauceglia P, Odunsi K. Expression and serum immunoreactivity of developmentally restricted differentiation antigens in epithelial ovarian cancer. Cancer immunity 2009; 9:6
  • Godoy H, Mhawech-Fauceglia P, Beck A, Miller A, Lele S, Odunsi K. Expression of poly (adenosine diphosphate-ribose) polymerase and p53 in epithelial ovarian cancer and their role in prognosis and disease outcome. International journal of gynecological pathology 2011; 30(2):139-144
  • Mhawech-Fauceglia P, Wang D, Kesterson J, Syriac S, Clark K, Frederick PJ, Lele S, Liu S. Gene expression profiles in stage I uterine serous carcinoma in comparison to grade 3 and grade 1 stage I endometrioid adenocarcinoma. PloS one 2011; 6(3):e18066
  • Morgan Jr RJ, Johnston C, Lele S, Matulonis UA, O'Malley DM, Penson RT, Remmenga SW, Sabbatini P, Schilder RJ, Schink JC, Teng N, Havrilesky LJ, Hakam A, Alvarez RD, Armstrong DK, Boston B, Burger RA, Chen L-M, Copeland L, Crispens MA, Gershenson D, Gray HJ, Grigsby PW, Werner TL. Epithelial ovarian cancer. Journal of the National Comprehensive Cancer Network : JNCCN 2011; 9(1):82-113
  • Akers S, Moysich K, Zhang W, Link P, Miller A, Lele S, Odunsi K, Karpf A. Association between global DNA hypomethylation in leukocytes and risk of ovarian cancer. Gynecologic oncology 2011; 121(1 Suppl.):100
  • Kesterson I, Kiran G, Ozerkan K, Kanis M, Groman A, Lele S. Evaluation of the outcome benefit conferred by intensive surveillance strategies in women with early-stage endometrial cancer. Gynecologic oncology 2011; 121(1 Suppl.):25
  • Kesterson J, Wang D, Akers S, duPont N, Clark K, Lele S, Liu S, Mhawech-Fauceglia P. The transforming growth factor beta signaling pathway in endometrial cancer: Expression and clinical significance. Gynecologic oncology 2011; 121(1 Suppl.):223
  • Syriac S, Durie N, Kesterson J, Lele S, Mhawech-Fauceglia P. Female adnexal tumor of probable Wolffian origin (FATWO) with recurrence 3 years postsurgery. International journal of gynecological pathology 2011; 30(3):231-235
  • Syriac S, Wang D, Kesterson J, Odunsi K, Lele S, Liu S, Mhawech-Fauceglia P. Differentially Expressed Genes in Early Stages Uterine Serous Carcinomas in Comparison to G3 and G1 Endometrioid Adenocarcinoma. Laboratory investigation 2011; 91(Suppl. 1):1139
  • Kesterson JP, Mhawech-Fauceglia P, Lele S. The use of bevacizumab in refractory ovarian granulosa-cell carcinoma with symptomatic relief of ascites: a case report. Gynecologic oncology 2008; 111(3):527-529
  • Kesterson JP, South S, Lele S. Squamous cell carcinoma of the vulva in a young woman with Crohn's disease. European journal of gynaecological oncology 2008; 29(6):651-652
  • Matsuzaki J, Qian F, Luescher I, Lele S, Ritter G, Shrikant PA, Gnjatic S, Old LJ, Odunsi K. Recognition of naturally processed and ovarian cancer reactive CD8+ T cell epitopes within a promiscuous HLA class II T-helper region of NY-ESO-1. Cancer immunology, immunotherapy : CII 2008; 57(8):1185-1195
  • Mhawech-Fauceglia P, Herrmann F, Bshara W, Zhang S, Penetrante R, Lele S, Odunsi K, Rodabaugh K. Intraobserver and interobserver variability in distinguishing between endocervical and endometrial adenocarcinoma on problematic cases of cervical curettings. International journal of gynecological pathology 2008; 27(3):431-436
  • Mhawech-Fauceglia P, Odunsi K, Dim D, Nowak N, Lele S, Cheney RT, Pejovic T. Array-comparative genomic hybridization analysis of primary endometrial and ovarian high-grade neuroendocrine carcinoma associated with adenocarcinoma: mystery resolved? . International journal of gynecological pathology 2008; 27(4):539-546
  • Mhawech-Fauceglia P, Rai H, Nowak N, Cheney RT, Rodabaugh K, Lele S, Odunsi K. The use of array-based comparative genomic hybridization (a-CGH) to distinguish metastatic from primary synchronous carcinomas of the ovary and the uterus. Histopathology 2008; 53(4):490-495
  • Partridge EE, Wilczynski S, Valea F, Trimble CL, Teng N, Smith-McCune K, Singh DK, Reynolds RK, Nava ME, Morgan M, Lipscomb GH, Lieberman RW, Lele SM, Greer BE, Fahey PJ, Campos S, Abu-Rustum N, National Comprehensive Cancer Network. Cervical cancer screening. Journal of the National Comprehensive Cancer Network : JNCCN 2008; 6(1):58-82
  • Shen J, Ambrosone CB, DiCioccio RA, Odunsi K, Lele SB, Zhao H. A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis 2008; 29(10):1963-1966
  • Smith R, Hicks D, Tomljanovich PI, Lele SB, Rajput A, Dunn KB. Adenocarcinoma arising from chronic perianal Crohn's disease: case report and review of the literature. American surgeon 2008; 74(1):59-61
  • Tchabo NE, Mhawech-Fauceglia P, Lele S. Primary squamous cell carcinoma of the endometrium: a case report. European journal of gynaecological oncology 2008; 29(5):527-530
  • Tosello V, Odunsi K, Souleimanian NE, Lele S, Shrikant P, Old LJ, Valmori D, Ayyoub M. Differential expression of CCR7 defines two distinct subsets of human memory CD4+CD25+ Tregs. Clinical immunology (Orlando, Fla.) 2008; 126(3):291-302
  • Odunsi K, Old LJ, Shrikant P, Lele S, Rodabaugh K, Thomas B, Villella J, Ritter G, Pan L, Hoffman EW, Andrews C, Mhawech-Fauceglia P, Matsuzaki J, Qian F, Gnjatic S. Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer. Proceedings of the National Academy of Sciences of the United States of America 2007; 104(31):12837-12842
  • Rodabaugh KJ, Mhawech-Fauceglia P, Groth J, Lele S, Sood AK. Prostate-derived Ets factor is overexpressed in serous epithelial ovarian tumors. International journal of gynecological pathology 2007; 26(1):10-15
  • Shamshirsaz AA, Withiam-Leitch M, Odunsi K, Baker T, Frederick PJ, Lele S. Young patients with endometrial carcinoma selected for conservative treatment: a need for vigilance for synchronous ovarian carcinomas, case report and literature review. Gynecologic oncology 2007; 104(3):757-760
  • Sharma S, Tammela J, Wang X, Arnouk H, Driscoll D, Mhawech-Fauceglia P, Lele S, Kazim AL, Odunsi K. Characterization of a putative ovarian oncogene, elongation factor 1alpha, isolated by panning a synthetic phage display single-chain variable fragment library with cultured human ovarian cancer cells. Clinical cancer research 2007; 13(19):5889-5896
  • Villella J, Herrmann FR, Kaul S, Lele S, Marchetti D, Natiella J, Odunsi K, Mhawech-Fauceglia P. Clinical and pathological predictive factors in women with adult-type granulosa cell tumor of the ovary. International journal of gynecological pathology 2007; 26(2):154-159
  • Mhawech-Fauceglia P, Pejovic T, Dim D, Fang X, Conroy J, Lele S, Cheney R, Odunsi K. Array-based comparative genomic hybridization (aCGH) analysis is a useful tool for distinguishing primary pulmonary from metastatic neuroendocrine carcinoma to the lung. Applied immunohistochemistry and molecular morphology : AIMM 2008; 16(3):291-295
  • Mhawech-Fauceglia P, Herrmann F, Lele S, Higgs D, South S, Schwaller J, Andrews C, Bshara W, Smiraglia DJ, Odunsi K. Prostate-specific membrane antigen expression is a potential prognostic marker in endometrial adenocarcinoma. Cancer epidemiology, biomarkers and prevention 2008; 17(3):571-577
  • Kanis M, Kesterson JP, Shroff S, Lele S, Mhawech-Fauceglia P. Malignant mixed mullerian tumor of primary peritoneal origin. Annals of diagnostic pathology 2011; 15(4):273-277
  • Mhawech-Fauceglia P, Kesterson J, Wang D, Akers S, Dupont NC, Clark K, Lele S, Liu S. Expression and clinical significance of the transforming growth factor-beta signalling pathway in endometrial cancer. Histopathology 2011; 59(1):63-72
  • Godoy HE, Kesterson JP, Eppolito C, Vethanayagam RR, Grimm MJ, Abrams S, Lele S, Segal BH, Odunsi K. NADPH Oxidase Modulates the Development of Myeloid-Derived Suppressor Cells (MDSCs) in Ovarian Cancer Tumor-Bearing Hosts. Reproductive sciences (Thousand Oaks, Calif.) 2011; 18(3):290A
  • Kesterson JP, Kanis M, Lele SB. Evaluation of the role of premetrexed in the treatment of refractory, recurrent epithelial ovarian cancer : ASCO Meeting Abstracts Part 1. Journal of clinical oncology 2011; 29(15 Suppl.):e15519
  • Jaggernauth WA, Tchabo N, Yang G, Yap J, Odunsi K, Rodabaugh K, Lele S, Singh A, Mc Closkey S. High distant failure rate despite good local control in high risk early stage endometrial cancer. International journal of radiation oncology, biology, physics 2008; 72(1 Suppl.):S366
  • Kesterson J, Lele SB. Evaluation of cardiac safety in patients with gynecologic malignancies receiving high cumulative doses of pegylated liposomal doxorubicin. Gynecologic oncology 2009; 112(2 Suppl. 1):114
  • Kesterson J, Lele SB, Odunsi KO, Shrikant P. Indoleamine 2,3-dioxygenase inhibition abrogates induction of regulatory T cells and promotes survival of ovarian tumor-bearing hosts. Gynecologic oncology 2009; 112(2 Suppl. 1):220
  • Mhawech-Fauceglia P, Bshara W, South S, Andrews C, Lele S, Odunsi K. PSMA mRNA and protein expression as potential prognostic markers in endometrial adenocarcinoma. Proceedings of the American Association for Cancer Research Annual Meeting 2007; 48:95-96
  • Odunsi K, Ghamande S, Macfee M, Yu AYC, Lele SB, Rodabaugh KJ, Thomas B, Zamboni WC. A phase II, pharmacokinetic (PK), and pharmacodynamic (PD) study of weekly docetaxel (DOC) in patients with platinum-resistant ovarian cancer. Journal of clinical oncology 2009; 27(15 Suppl.):Abstract #e16531
  • Odunsi K, Kesterson J, Qian F, Lele S, Shrikant P. Inhibition of IDO Abrogates Induction of Tregs and Promotes Survival of Ovarian Tumor Bearing Hosts. Reproductive sciences (Thousand Oaks, Calif.) 2009; 16(3 Suppl.):71
  • Odunsi K, Kowalski D, Mhawech-Fauceglia P, Andrews C, Lele S, Huang RY. Inhibition of Serine-Arginine Protein Kinase 1 (SRPK1) Overcomes Platinum Resistance in Ovarian Cancer. Reproductive sciences (Thousand Oaks, Calif.) 2009; 16(3 Suppl.):283
  • Odunsi K, Qian F, Villella J, Mhawech-Fauceglia P, Andrews C, Matsuzaki J, Frederick PJ, Cheney R, Moysich K, Lele S, Shrikant P, Old LJ. Tryptophan degradation by indoleamine 2,3-dioxygenase promotes preferential accumulation of CD4(+)CD25(high)FOXP3(+) regulatory T cells in human ovarian cancer. Gynecologic oncology 2008; 108(3 Suppl. 1):338
  • Rai G, Kunle O, Lele S, Mhawech-Fauceglia P. A molecular genetic approach using array comparative genomic hybridization (aCGH) analysis in distinguishing synchronous versus metastatic carcinoma arising concurrently in the ovary and the endometrium. Laboratory investigation 2008; 88(Suppl. 1):220A (Abstract #1005)
  • Singhal P, Mischo A, Li QS, Eppolito C, Tsuji M, Franke M, Lele S, Odunsi K, Shrikant P. The natural killer T-cell ligand alpha-C-galactosylceramide promotes ovarian cancer survival by dual regulation of the adaptive host immunity. Gynecologic oncology 2007; 104(3 Suppl. 1):S21-S22
  • Singhal P, Villella J, Andrews C, Lele S, Odunsi K. BORIS and FATE co-expression is a prognostic indicator in patients with epithelial ovarian cancer. Gynecologic oncology 2008; 108(3 Suppl. 1):195
  • Singhal PK, Shahzad MM, Odunsi KO, Lele SB. Platinum, adriamycin and VP-16 versus paclitaxel and carboplatin for treatment of advanced or recurrent endometrial carcinoma. Gynecologic oncology 2009; 112(2 Suppl. 1):121
  • South SA, Asubonten KO, Andrews C, Rodabaugh K, Odunsi K, Lele S. Weight loss after surgery impacts overall survival in epithelial ovarian cancer. Gynecologic oncology 2008; 108(3 Suppl. 1):347
  • Tchabo NE, Cabellero O, Mhawech-Fauceglia P, Andrews C, Lele SB, Odunsi KO. Developmentally restricted differentiation antigens in ovarian cancer. Gynecologic oncology 2009; 112(2 Suppl. 1):364
  • Riebandt G, Rodabaugh KJ, Pietkiewicz J, Fong MK, Groman AE, Lele SB, Odunsi K, Akers S. Prospective analysis of chemotherapy-induced neuropathy in patients with gynecologic malignancies : ASCO Meeting Abstracts Part 1. Journal of clinical oncology 2011; 29(15 Suppl.):e19737
  • Agnani D, Camacho-Vanegas O, Camacho C, Lele S, Odunsi K, Cohen S, Dottino P, Martignetti JA. Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression. Journal of ovarian research 2011; 4:18
  • Gruber TJ, Fabiano AJ, Deeb G, Lele SB, Fenstermaker RA. Intracranial meningiomas in patients with uterine sarcoma treated with long-term megestrol acetate therapy. World neurosurgery 2011; 76(5):477.e16-477.e20
  • Mhawech-Fauceglia P, Wang D, Lele S, Frederick PJ, Pejovic T, Liu S. Claudin7 and moesin in endometrial Adenocarcinoma; a retrospective study of 265 patients. BMC research notes 2012; 5 :65
  • Shen J, Wang D, Gregory SR, Medico L, Hu Q, Yan L, Odunsi K, Lele SB, Ambrosone CB, Liu S, Zhao H. Evaluation of microRNA expression profiles and their associations with risk alleles in lymphoblastoid cell lines of familial ovarian cancer. Carcinogenesis 2012; 33(3):604-612
  • Akers S, Khulpateea B, Groman A, Kesterson J, Odunsi K, Lele S, Frederick P. Adjuvant treatment for uterine leiomyosarcoma. Gynecologic oncology 2012; 125(Suppl. 1):S159
  • Beck TL, Singhal PK, Ehrenberg HM, Rose PG, Lele SB, Krivak TC, McBee WC. Endometrial stromal sarcoma: analysis of recurrence following adjuvant treatment. Gynecologic oncology 2012; 125(1):141-144
  • Dewdney SB, Kizer NT, Andaya AA, Babb SA, Luo J, Mutch DG, Schmidt AP, Brinton LA, Broaddus RR, Ramirez NC, Huettner PC, McMeekin DS, Darcy K, Ali S, Judson PL, Mannel RS, Lele SB, O'Malley DM, Goodfellow PJ. Uterine serous carcinoma: increased familial risk for lynch-associated malignancies. Cancer prevention research (Philadelphia, Pa.) 2012; 5(3):435-443
  • Godoy H, Vaddadi P, Cooper M, Frederick P, Odunsi K, Lele S. Photodynamic therapy effectively palliates gynecologic malignancies. Gynecologic oncology 2012; 125(Suppl. 1):S81
  • Odunsi K, Matsuzaki J, Karbach J, Neumann A, Mhawech-Fauceglia P, Miller A, Beck A, Morrison CD, Ritter G, Godoy H, Lele S, DuPont N, Edwards R, Shrikant P, Old LJ, Gnjatic S, Jager E. Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients. Proceedings of the National Academy of Sciences of the United States of America 2012; 109(15):5797-5802
  • Vaddadi P, Godoy H, Kesterson J, Tolentino J, Frederick P, Dupont N, Lele S, Odunsi K. Identification of a subset of stage IV ovarian carinomas with improved overall survival. Gynecologic oncology 2012; 125(Suppl. 1):S102
  • Mhawech-Fauceglia P, Wang D, Samrao D, Godoy H, Ough F, Liu S, Pejovic T, Lele S. Pair Box 8 (PAX8) protein expression in high grade, late stage (stages III and IV) ovarian serous carcinoma. Gynecologic oncology 2012; 127(1):198-201
  • Mhawech-Fauceglia P, Wang D, Samrao D, Godoy H, Pejovic T, Liu S, Lele S. Pair-Box (PAX8) protein-positive expression is associated with poor disease outcome in women with endometrial cancer. British journal of cancer 2012; 107(2):370-374
  • Mhawech-Fauceglia P, Wang D, Samrao D, Menesses T, Godoy H, Ough F, Lele S, Liu S, Pejovic T. The role of hypoxic-inducible factor (HIF1α) and aldolaseC protein in endometrial carcinogenesis: a retrospective study of 279 patients. BMJ open 2012; 2(4):e001450
Referral
Email: 
Shashi.Lele@RoswellPark.org
Fax: 
716-845-7608
Source URL (retrieved on 06/18/2013 - 5:26pm): http://www.roswellpark.org/shashikant-lele